Toll-like receptor 2 expression on monocytes and microvascular complications in type 2 diabetic patients
Authors:
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 13 (2) , 1299-1302
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Prevalence and complications of diabetes mellitus in Northern Africa, a systematic reviewBMC Public Health, 2013
- Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathyAmerican Journal of Physiology-Renal Physiology, 2012
- Toll-Like Receptor 4 Promotes Tubular Inflammation in Diabetic NephropathyJournal of the American Society of Nephrology, 2012
- Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complicationsMetabolism, 2011
- Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic SubjectsDiabetes Care, 2010
- Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetesAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Toll‐like receptor 4 in atherosclerosisJournal of Cellular and Molecular Medicine, 2007
- Toll-like receptors and innate immunityJournal of Molecular Medicine, 2006
- Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetesNature Genetics, 2006
- Toll-like Receptors and Atherosclerosis: Key Contributors in Disease and Health?Immunologic Research, 2006